Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.25) by 16 percent. This is a 10.53 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $606.927 million which missed the analyst consensus estimate of $615.391 million by 1.38 percent. This is a 3.95 percent decrease over sales of $631.900 million the same period last year.